344 related articles for article (PubMed ID: 16445943)
1. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Siman-Tov T; Meiner V; Gadoth N
J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
[TBL] [Abstract][Full Text] [Related]
2. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
Heller R; Grau AJ; Schäbitz WR; Schwaninger M
Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
[TBL] [Abstract][Full Text] [Related]
4. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Moghadasian MH
Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
[TBL] [Abstract][Full Text] [Related]
5. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
[TBL] [Abstract][Full Text] [Related]
6. [Cerebrotendinous xanthomatosis].
Burghaus L; Liu W; Haupt WF
Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
[TBL] [Abstract][Full Text] [Related]
7. Presenile cataract: consider cholestanol.
Tészás A; Pfund Z; Morava E; Kosztolányi G; Sistermans E; Wevers RA; Kellermayer R
Arch Ophthalmol; 2006 Oct; 124(10):1490-2. PubMed ID: 17030721
[No Abstract] [Full Text] [Related]
8. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
9. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
Takahashi M; Okazaki H; Tada H; Ishibashi S
J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
[TBL] [Abstract][Full Text] [Related]
10. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
Sperhake JP; Matschke J
Nervenarzt; 2004 Jun; 75(6):608. PubMed ID: 15257383
[No Abstract] [Full Text] [Related]
12. Cholestanol metabolism, molecular pathology, and nutritional implications.
Seyama Y
J Med Food; 2003; 6(3):217-24. PubMed ID: 14585188
[TBL] [Abstract][Full Text] [Related]
13. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
Preiss Y; Santos JL; Smalley SV; Maiz A
Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
[TBL] [Abstract][Full Text] [Related]
14. Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.
de Sain-van der Velden MG; Verrips A; Prinsen BH; de Barse M; Berger R; Visser G
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S387-93. PubMed ID: 18949577
[TBL] [Abstract][Full Text] [Related]
15. [Cerebrotendinous xanthomatosis (CTX)].
Kinoshita M; Teramoto T
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):111-4. PubMed ID: 9645021
[No Abstract] [Full Text] [Related]
16. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
Salen G; Steiner RD
J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
[TBL] [Abstract][Full Text] [Related]
18. Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans.
Björkhem I; Leitersdorf E
Trends Endocrinol Metab; 2000 Jul; 11(5):180-3. PubMed ID: 10856919
[TBL] [Abstract][Full Text] [Related]
19. Spinal phenotype of cerebrotendinous xanthomatosis--a pitfall in the diagnosis of multiple sclerosis.
Bartholdi D; Zumsteg D; Verrips A; Wevers RA; Sistermans E; Hess K; Jung HH
J Neurol; 2004 Jan; 251(1):105-7. PubMed ID: 14999499
[No Abstract] [Full Text] [Related]
20. Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.
Mandia D; Chaussenot A; Besson G; Lamari F; Castelnovo G; Curot J; Duval F; Giral P; Lecerf JM; Roland D; Pierdet H; Douillard C; Nadjar Y
J Neurol; 2019 Aug; 266(8):2043-2050. PubMed ID: 31115677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]